Skip to main content
Log in

Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle

  • Short Communication
  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

This study compared pharmacokinetic profiles in cattle dosed subcutaneously with two different formulations of enrofloxacin (5% and 10%) at a dose of 5 mg/kg. Plasma concentrations of enrofloxacin and its active metabolite, ciprofloxacin, were determined by a HPLC/u.v. method. The pharmacokinetic parameters of enrofloxacin and its metabolite were similar in both injectable formulations. Enrofloxacin peak plasma concentration (5%: 0.73 ± 0.32; 10%: 0.60 ± 0.14 μg/mL) was reached at 1.21 ± 0.52 and 1.38 ± 0.52 h to 5 and 10%, respectively. The terminal half-live and area under curve were 2.34 ± 0.46 and 2.59 ± 0.46 h, and 3.09 ± 0.81 and 2.93 ± 0.58 μg·h/mL, to 5 and 10%, respectively. The AUC/MIC90 and Cmax/MIC90 ratios for both formulations exceed the proposed threshold values for optimized efficacy and minimized resistance development whilst treating infections or septicaemia caused by P. multocida and E. coli.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  • De Lucas, J.J., Rodríguez, C., Waxman, S., González, F., de Vicente, M.L. and San Andrés, M.I., 2004. Pharmacokinetics of enrofloxacin after single intravenous and intramuscular administration in young domestic ostrich (Struthio camelus), Journal of Veterinary Pharmacology and Therapeutics, 27, 119–122.

    Article  PubMed  CAS  Google Scholar 

  • Gandolf A.R., Papich, M.G., Bringardner, A.B. and Atkinson, M.W., 2005. Pharmacokinetics after intravenous, subcutaneous, and oral administration of enrofloxacin to alpacas, American Journal of Veterinary Research, 66, 767–771.

    Article  PubMed  CAS  Google Scholar 

  • Grobbel, M., Lübke-Becker, A., Wieler, L. H., Froyman, R., Friederichs, S. and Filios, S., 2007. Comparative quantification of the in vitro activity of veterinary fluoroquinolones. Veterinary Microbiology, 124, 73–81.

    Article  PubMed  CAS  Google Scholar 

  • Hoeben, B.D., Monfardini, E., Burvenich, C. and Hamann, J., 2000. Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: effect on clinical signs and chemiluminescence of circulating neutrophils, Journal of Dairy Research, 67, 485–502.

    Article  PubMed  CAS  Google Scholar 

  • Kaartinen, L., Salonen, M., Älli, L. and Pyörälä, S., 1995. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows, Journal of Veterinary Pharmacology and Therapeutics 18, 357–362.

    PubMed  CAS  Google Scholar 

  • McKellar, Q.A., 1996. Clinical relevance of pharmacologic properties of fluoroquinolones, Compendium on Continuing Education for the Practicing Veterinarian, 18(Suppl.), 14–21.

    Google Scholar 

  • McKellar, Q.A., Gibson, I., Monteiro, A. and Bregante, M., 1999. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy. 43, 1988–1992.

    PubMed  CAS  Google Scholar 

  • McKellar, Q.A., Sánchez-Bruni, S.F. and Jones, D.G., 2004. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503–514.

    Article  PubMed  CAS  Google Scholar 

  • Prescott, J.F. and Yielding, K.M., 1990. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research, 54, 195–197.

    PubMed  CAS  Google Scholar 

  • Rahal, A., Kumar, A., Ahmad, A.H., Malik, J.K. and Ahuja, V., 2006. Pharmacokinetics of enrofloxacin in sheep following intravenous and subcutaneous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 321–324.

    Article  PubMed  CAS  Google Scholar 

  • Ramesh, S., Rao, G.S. and Malik, J.K., 2002: Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats. Veterinary Research Communications, 26, 563–569.

    Article  PubMed  CAS  Google Scholar 

  • Wallmann, J., 2006. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals. International Journal of Medical Microbiology, 296 S2, 81–86.

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Mr. Mariano Díaz-Flores for his technical assistance. Thanks to the staff of the Biblioteca de la Facultad de Veterinaria (BUCM) for their invaluable help. This study was supported by a grant from the Bayer Health Care, AG (348/2001 Art. 83 LRU/UCM). Special thanks to Mr Enrique Rierola, from Química Farmacéutica Bayer, S.A. (Barcelona, Spain) and Ms. Isabel Uriarte Inchausti (DVM).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Rodríguez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Lucas, J.J., San Andrés, M.I., González, F. et al. Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle. Vet Res Commun 32, 275–279 (2008). https://doi.org/10.1007/s11259-008-9037-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11259-008-9037-y

Keywords

Navigation